Performance analysis of Protalix BioTherapeutics (PLX)
Annual Return
Over the past 3 years, PLX has had an average annual return of +13.27%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, PLX has had an average annual return of +7.62%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, PLX has had an average annual return of -9.31%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Nov 1, 1999, PLX has had an average annual return of -13.01%, underperforming the benchmark SPY, which returned +8.46% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +33.89% | -4.26% | +5.62% | +29.93% | +65.06% | -77.13% | +10.67% | +5.47% | -52.95% | +48.54% | -56.37% | -44.57% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -52.70% | -25.05% | +5.27% | -50.60% | +50.76% | +259.78% | -45.88% | -79.64% | -60.71% | +2,025% | -50.00% | +263.64% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -52.17% | +22.99% | -78.63% | -12.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +30% | +23.08% | -24.65% | -0.92% | -1.86% | +10.43% | +3.43% | +33.89% | |||||
| 2025 | +29.26% | -4.12% | +9.87% | +19.92% | -49.51% | -4.52% | -1.35% | +6.16% | +43.23% | +6.76% | -24.89% | +1.12% | -4.26% |
| 2024 | -18.54% | +12.41% | -22.70% | -9.52% | -0.88% | +3.54% | -7.69% | -12.96% | +8.51% | +14.71% | +47.01% | +9.30% | +5.62% |
| 2023 | +13.87% | +24.36% | +8.25% | +32.38% | -24.82% | -4.31% | -20.00% | +18.13% | -12.17% | +0.60% | -9.58% | +17.88% | +29.93% |
| 2022 | +1.20% | +0% | +26.19% | +9.43% | +1.72% | -7.63% | -2.75% | +4.72% | -6.31% | -0.96% | +6.80% | +24.55% | +65.06% |
| 2021 | +20.66% | +11.87% | -8.98% | -24.89% | -9.25% | -37.17% | -20.94% | +8.61% | -18.90% | -15.04% | -17.70% | -10.75% | -77.13% |
| 2020 | +12.80% | -10.81% | -28.79% | +59.57% | -10.93% | +13.47% | -5.54% | +2.79% | +5.16% | -15.50% | +9.79% | +1.11% | +10.67% |
| 2019 | +56.27% | -2.67% | -6.98% | -0.68% | -15.33% | +26.76% | -20.04% | -44.80% | -0.97% | +7.32% | +41.36% | +5.47% | +5.47% |
| 2018 | +4.39% | -2.75% | -19.52% | -24.07% | +18.54% | -11.52% | +13.95% | -2.04% | +51.46% | -32.60% | -11.43% | -28.34% | -52.95% |
| 2017 | +41.57% | +66.67% | +29.52% | -31.62% | -3.23% | -6.89% | -18.85% | -22.50% | +10.06% | +34.14% | -11.31% | -4.20% | +48.54% |
Drawdown analysis of Protalix BioTherapeutics (PLX)
The maximum drawdown for the PLX was -99.85%, occurring on Dec 3, 2021. This drawdown has not yet recovered.
The current PLX drawdown is -99.55%.
Since Nov 1, 1999 PLX has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.85% | Jun 14, 2006 | 3896 | Dec 3, 2021 | Ongoing | Ongoing | Ongoing |
| -94.34% | Nov 2, 1999 | 39 | Dec 29, 1999 | 1494 | Dec 7, 2005 | 1533 |
| -31.51% | Dec 12, 2005 | 110 | May 22, 2006 | 16 | Jun 14, 2006 | 126 |